Location History:
- Menlo Park, CA (US) (2006 - 2009)
- Palo Ato, CA (US) (2014)
- Sunnyvale, CA (US) (2017 - 2022)
- Palo Alto, CA (US) (2014 - 2023)
Company Filing History:
6 out of 560 
3 out of 59 
2 out of 5,307 
Years Active: 2006-2023
Title: The Innovative Contributions of Eugeni A Namsaraev
Introduction
Eugeni A Namsaraev is a prominent inventor based in Sunnyvale, California. He has made significant contributions to the field of biotechnology, particularly in the analysis of nucleic acids. With a total of 11 patents to his name, Namsaraev's work has the potential to impact cancer detection and diagnostics.
Latest Patents
Namsaraev's latest patents include innovative methods for analyzing nucleic acid fragments. These methods provide techniques for enriching biological samples for target nucleic acids, especially those associated with cancer or tumors. His work also involves the use of probes to enhance the analysis of these nucleic acids. Another notable patent focuses on improving the positive predictive value for cancer detection using cell-free nucleic acid samples. This includes the analysis of fragmentation patterns and sizes of cell-free DNA, which can help determine the presence and stage of cancer in subjects.
Career Highlights
Throughout his career, Namsaraev has worked with notable companies such as Affymetrix, Inc. and Grail, Inc. His experience in these organizations has allowed him to develop and refine his innovative approaches to nucleic acid analysis.
Collaborations
Namsaraev has collaborated with esteemed colleagues, including Xin Miao and John E Blume. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Eugeni A Namsaraev's contributions to biotechnology and cancer diagnostics through his patents demonstrate his innovative spirit and dedication to improving healthcare. His work continues to pave the way for advancements in the detection and analysis of critical biological markers.